Lifeway Foods Delivers Record Q2 2025 Net Sales, Extends Kefir Category Leadership, and Estimates Over 20% Q3 Net Sales Growth to Date
Lifeway Foods (Nasdaq: LWAY) reported exceptional Q2 2025 results with record net sales of $53.9 million, representing an 18% volume-led increase on a comparable basis. The company achieved significant milestones including gross margin expansion of 160 basis points year-over-year to 28.6% and net income of $4.2 million ($0.28 per share).
The momentum continues into Q3 2025, with unaudited net sales reaching $26.4 million through August 11, up over 20% year-over-year. July marked a historic achievement with the highest weekly sales ever recorded, exceeding $5.5 million. The company maintains its long-term target of $45-$50 million in Adjusted EBITDA for FY 2027.
Lifeway Foods (Nasdaq: LWAY) ha riportato risultati eccezionali nel secondo trimestre 2025 con ricavi netti record di $53.9 milioni, pari a un aumento del 18% trainato dai volumi su base comparabile. L'azienda ha raggiunto traguardi importanti, tra cui un'espansione del margine lordo di 160 punti base su base annua, al 28,6%, e un utile netto di $4.2 milioni ($0.28 per azione).
Il trend prosegue nel terzo trimestre 2025: le vendite nette non revisionate hanno raggiunto $26.4 milioni fino all'11 agosto, in crescita di oltre il 20% rispetto all'anno precedente. Luglio ha segnato un primato storico con la migliore settimana di vendite mai registrata, oltre $5.5 milioni. L'azienda conferma il suo obiettivo a lungo termine di $45-$50 milioni di EBITDA rettificato per l'esercizio 2027.
Lifeway Foods (Nasdaq: LWAY) presentó resultados excepcionales en el segundo trimestre de 2025 con ventas netas récord de $53.9 millones, un aumento del 18% impulsado por volumenes en base comparable. La compañía alcanzó hitos importantes, incluyendo una ampliación del margen bruto de 160 puntos básicos interanual hasta el 28.6% y un beneficio neto de $4.2 millones ($0.28 por acción).
El impulso continúa en el tercer trimestre de 2025: las ventas netas no auditadas alcanzaron $26.4 millones hasta el 11 de agosto, más de un 20% interanual. Julio registró un hito histórico con la semana de ventas más alta de la compañía, superando los $5.5 millones. La compañía mantiene su objetivo a largo plazo de $45-$50 millones de EBITDA ajustado para el año fiscal 2027.
Lifeway Foods (Nasdaq: LWAY)는 2025년 2분기에 순매출 사상 최고치 $53.9M을 기록하며 우수한 실적을 발표했습니다. 이는 비교 기준으로 물량 중심의 18% 증가에 해당합니다. 회사는 연간 기준 매출총이익률이 160 베이시스포인트 개선되어 28.6%로 상승했으며, 순이익 $4.2M (주당 $0.28)을 달성하는 등 주요 성과를 보였습니다.
이 같은 모멘텀은 2025년 3분기에도 이어져, 감사되지 않은 순매출이 8월 11일 기준 $26.4M에 달해 전년 대비 20% 이상 증가했습니다. 7월에는 주간 기준 사상 최고 매출을 기록하며 $5.5M를 상회했습니다. 회사는 2027 회계연도에 대한 장기 목표로 조정 EBITDA $45-$50M을 유지하고 있습니다.
Lifeway Foods (Nasdaq: LWAY) a publié des résultats exceptionnels au deuxième trimestre 2025 avec des ventes nettes records de $53.9 millions, soit une hausse de 18% tirée par les volumes sur une base comparable. La société a atteint des jalons importants, notamment une augmentation de la marge brute de 160 points de base en glissement annuel, à 28,6%, et un résultat net de $4.2 millions (0,28 $ par action).
La dynamique se poursuit au troisième trimestre 2025, avec des ventes nettes non auditées de $26.4 millions au 11 août, en hausse de plus de 20% par rapport à l'année précédente. Juillet a marqué un record historique avec la meilleure semaine de ventes jamais enregistrée, dépassant $5.5 millions. La société maintient son objectif à long terme de 45-50 millions de dollars d'EBITDA ajusté pour l'exercice 2027.
Lifeway Foods (Nasdaq: LWAY) meldete hervorragende Ergebnisse im 2. Quartal 2025 mit rekordverdächtigen Nettoumsätzen von $53.9 Mio., was einem volumengetriebenen Anstieg von 18% auf vergleichbarer Basis entspricht. Das Unternehmen erreichte wichtige Meilensteine, darunter eine Ausweitung der Bruttomarge um 160 Basispunkte im Jahresvergleich auf 28,6% sowie einen Nettogewinn von $4.2 Mio. ($0.28 je Aktie).
Die Dynamik setzt sich im 3. Quartal 2025 fort: nicht geprüfte Nettoumsätze beliefen sich bis zum 11. August auf $26.4 Mio., ein Anstieg von über 20% gegenüber dem Vorjahr. Im Juli wurde mit dem höchsten jemals verzeichneten Wochenumsatz von über $5.5 Mio. ein Rekord erzielt. Das Unternehmen bestätigt sein langfristiges Ziel von $45-$50 Mio. bereinigtem EBITDA für das Geschäftsjahr 2027.
- Record Q2 net sales of $53.9 million, up 18% on comparable basis
- Gross margin expanded 160 basis points to 28.6% year-over-year
- Net income increased to $4.2 million, with EPS growth to $0.28
- Q3 2025 showing accelerated growth with net sales up over 20% YoY
- Highest weekly sales ever recorded in July 2025, surpassing $5.5 million
- Named Processor of the Year by Dairy Foods magazine
- SG&A expenses at 17.6% of net sales due to increased marketing and distribution investments
Insights
Lifeway delivered record Q2 sales with strong margins and accelerating Q3 momentum, driven by volume growth in kefir products.
Lifeway Foods has delivered another exceptional quarter with record net sales of
The
The Q3 momentum appears to be building even stronger, with unaudited net sales already reaching
While SG&A expenses remained elevated at
Kefir market leader posts
Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year
Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of
"This was another quarter that reinforces Lifeway's position as the undisputed leader in the kefir category," said Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods. "We delivered
Smolyansky continued, "Beyond topline growth, we expanded gross margin by 160 basis points year-over-year and more than 460 basis points sequentially, translating into double-digit net income and diluted EPS growth year-over-year. We are executing with discipline while capturing powerful consumer tailwinds – from the continued wellness boom to the surge in GLP-1 medication use – as more people seek nutrient-dense, protein-rich, probiotic foods that support digestion, satiety, and natural GLP-1 hormone production."
Recognized Industry Leadership
In July, Lifeway was named Processor of the Year by Dairy Foods magazine, the publication's highest annual honor, recognizing the Company's innovation, leadership, growth, and impact on the dairy industry. "Earning this award is a testament to our team's dedication and to the role Lifeway has played in pioneering kefir in the
Capitalizing on Growth Trends
In addition to its flagship kefir and Farmer Cheese, Lifeway's Probiotic Smoothies with Collagen – the first in the category – are resonating strongly with consumers. Collagen, a rapidly growing
Third Quarter Momentum
Momentum has carried into the second half of the year. In July, Lifeway recorded the highest single week of gross sales in Company history, surpassing
Second Quarter 2025 Highlights
- Net Sales:
, highest in Company history, up$53.9 million 9.7% year-over-year and approximately18% on a comparable basis, adjusted for a customer relationship the Company strategically exited in the third quarter of 2024, and a distributor shifting from Lifeway delivered to customer pick-up in late 2024, resulting in lower net sales and lower freight expense. - Gross Profit Margin:
28.6% , up from27.0% last year - SG&A:
17.6% of net sales, reflecting continued investment in marketing and distribution - Net Income:
, or$4.2 million per basic and diluted common share, compared to$0.28 , or$3.8 million per basic and$0.26 per diluted share in the prior year$0.25
Outlook
The Company reiterated its long-term target of
"We are just getting started," Smolyansky concluded. "With record sales, expanding margins, category-leading innovation, and a production platform ready to scale, Lifeway is positioned for sustained, profitable growth. The best is yet to come."
- Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is defined as Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation.
Conference Call and Webcast
A webcast with Lifeway's President and Chief Executive Officer discussing these results with additional comments and details is available through the "Investor Relations" section of the Company's website at https://lifewaykefir.com/webinars-reports/.
About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the Company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, the drivers of demand for Lifeway's products, consumer trends, the anticipated effects of scheduled upgrades at the Waukesha plant, expected operating efficiencies and expectations regarding future operating and financial performance. These statements use words, and variations of words, such as "will," "continue," "future," "increase," "believe," "outlook," "expect," and "predict." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this press release, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond Lifeway's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from Lifeway's expectations and projections. These risks, uncertainties, and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; customer acceptance of products and services; and uncertainty regarding proposals or other actions taken by shareholders related to the unsolicited proposal made by Danone North America PBC ("Danone") to acquire all of the shares of Lifeway stock that Danone does not already own. A further list and description of these risks, uncertainties, and other factors can be found in Lifeway's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Copies of these filings are available online at https://www.sec.gov, http://lifewaykefir.com/investor-relations/, or on request from Lifeway. Lifeway expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.
Non-GAAP Financial Measures
This press release refers to Adjusted EBITDA, which is a financial measure that has not been prepared in accordance with
We are unable to reconcile our target fiscal year 2027 Adjusted EBITDA to projected net income, the most directly comparable projected GAAP financial measure, because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Due to this uncertainty, the Company cannot reconcile target fiscal year 2027 Adjusted EBITDA to the nearest GAAP financial measure without unreasonable effort.
Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net
Perceptual Advisors
Dan Tarman
Email: dtarman@perceptualadvisors.com
General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net
LIFEWAY FOODS, INC. AND SUBSIDIARIES | ||||||||
June 30, 2025 | December 31, | |||||||
(Unaudited) | 2024 | |||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 21,220 | $ | 16,728 | ||||
Accounts receivable, net of allowance for credit losses and discounts & allowances of | 16,065 | 15,424 | ||||||
Inventories, net | 10,224 | 8,678 | ||||||
Prepaid expenses and other current assets | 1,822 | 2,144 | ||||||
Refundable income taxes | – | 631 | ||||||
Total current assets | 49,331 | 43,605 | ||||||
Property, plant and equipment, net | 30,731 | 26,862 | ||||||
Operating lease right-of-use asset | 278 | 118 | ||||||
Goodwill | 11,704 | 11,704 | ||||||
Intangible assets, net | 6,088 | 6,358 | ||||||
Other assets | 135 | 1,900 | ||||||
Total assets | $ | 98,267 | $ | 90,547 | ||||
Current liabilities | ||||||||
Accounts payable | $ | 11,880 | $ | 10,401 | ||||
Accrued expenses | 4,409 | 5,103 | ||||||
Total current liabilities | 16,289 | 15,504 | ||||||
Operating lease liabilities | 220 | 70 | ||||||
Deferred income taxes, net | 3,062 | 3,062 | ||||||
Total liabilities | 19,571 | 18,636 | ||||||
Stockholders' equity | ||||||||
Preferred stock, no par value; 2,500 shares authorized; none issued | – | – | ||||||
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,221 | 6,509 | 6,509 | ||||||
Treasury stock, at cost | (13,268) | (14,052) | ||||||
Paid-in capital | 2,844 | 4,632 | ||||||
Retained earnings | 82,611 | 74,822 | ||||||
Total stockholders' equity | 78,696 | 71,911 | ||||||
Total liabilities and stockholders' equity | $ | 98,267 | $ | 90,547 |
LIFEWAY FOODS, INC. AND SUBSIDIARIES | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net sales | $ | 53,901 | $ | 49,157 | $ | 99,992 | $ | 93,791 | ||||||||
Cost of goods sold | 37,669 | 35,181 | 71,923 | 67,619 | ||||||||||||
Depreciation expense | 832 | 701 | 1,634 | 1,362 | ||||||||||||
Total cost of goods sold | 38,501 | 35,882 | 73,557 | 68,981 | ||||||||||||
Gross profit | 15,400 | 13,275 | 26,435 | 24,810 | ||||||||||||
Selling expense | 4,718 | 3,577 | 9,416 | 7,277 | ||||||||||||
General and administrative expense | 4,752 | 4,177 | 9,380 | 8,313 | ||||||||||||
Amortization expense | 135 | 135 | 270 | 270 | ||||||||||||
Total operating expenses | 9,605 | 7,889 | 19,066 | 15,860 | ||||||||||||
Income from operations | 5,795 | 5,386 | 7,369 | 8,950 | ||||||||||||
Other income (expense): | ||||||||||||||||
Interest expense | (21) | (47) | (35) | (98) | ||||||||||||
Fair Value Loss on investments | – | – | (20) | – | ||||||||||||
Gain on sale of investments | 55 | – | 3,407 | – | ||||||||||||
Other income (expense), net | 82 | 20 | 156 | 15 | ||||||||||||
Total other income (expense) | 116 | (27) | 3,508 | (83) | ||||||||||||
Income before provision for income taxes | 5,911 | 5,359 | 10,877 | 8,867 | ||||||||||||
Provision for income taxes | 1,662 | 1,576 | 3,088 | 2,658 | ||||||||||||
Net income | $ | 4,249 | $ | 3,783 | $ | 7,789 | $ | 6,209 | ||||||||
Net earnings per common share: | ||||||||||||||||
Basic | $ | 0.28 | $ | 0.26 | $ | 0.51 | $ | 0.42 | ||||||||
Diluted | $ | 0.28 | $ | 0.25 | $ | 0.51 | $ | 0.41 | ||||||||
Weighted average common shares outstanding: | ||||||||||||||||
Basic | 15,206 | 14,727 | 15,170 | 14,709 | ||||||||||||
Diluted | 15,390 | 15,197 | 15,359 | 15,176 |
LIFEWAY FOODS, INC. AND SUBSIDIARIES | ||||||||
Six months ended June 30, | ||||||||
2025 | 2024 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 7,789 | $ | 6,209 | ||||
Adjustments to reconcile net income to operating cash flow: | ||||||||
Depreciation and amortization | 1,904 | 1,632 | ||||||
Stock-based compensation | 927 | 1,296 | ||||||
Non-cash interest expense | 9 | 17 | ||||||
Gain on sale of equipment | (115) | – | ||||||
Gain on sale of investments | (3,407) | – | ||||||
Fair value loss on investment | 20 | – | ||||||
(Increase) decrease in operating assets: | ||||||||
Accounts receivable | (640) | (651) | ||||||
Inventories | (1,546) | 650 | ||||||
Prepaid expenses and other current assets | 322 | 531 | ||||||
Refundable income taxes | 631 | (180) | ||||||
Increase (decrease) in operating liabilities: | ||||||||
Accounts payable | 500 | (574) | ||||||
Accrued expenses | (2,632) | (366) | ||||||
Accrued income taxes | – | (474) | ||||||
Net cash provided by operating activities | 3,762 | 8,090 | ||||||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (4,526) | (3,905) | ||||||
Proceeds from sale of equipment | 115 | – | ||||||
Proceeds from sale of investments | 5,206 | – | ||||||
Net cash provided by (used in) investing activities | 795 | (3,905) | ||||||
Cash flows from financing activities: | ||||||||
Repayment of note payable | – | (2,750) | ||||||
Payment of deferred financing costs | (65) | – | ||||||
Net cash used in financing activities | (65) | (2,750) | ||||||
Net increase in cash and cash equivalents | 4,492 | 1,435 | ||||||
Cash and cash equivalents at the beginning of the period | 16,728 | 13,198 | ||||||
Cash and cash equivalents at the end of the period | $ | 21,220 | $ | 14,633 | ||||
Supplemental cash flow information: | ||||||||
Cash paid for income taxes, net of (refunds) | $ | 2,457 | $ | 3,312 | ||||
Cash paid for interest | $ | 26 | $ | 89 | ||||
Non-cash investing activities | ||||||||
Accrued purchase of property and equipment | $ | 1,083 | $ | 106 | ||||
Right-of-use assets obtained in exchange for lease obligations | $ | 196 | $ | – |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-delivers-record-q2-2025-net-sales-extends-kefir-category-leadership-and-estimates-over-20-q3-net-sales-growth-to-date-302527755.html
SOURCE Lifeway Foods, Inc.